Affiliations: [a] Stead Family Department of Pediatrics, University of Iowa Children’s Hospital, Iowa City, IA, USA
| [b] Iowa Statewide Perinatal Care Program, Iowa Department of Public Health, Des Moines, IA, USA
| [c] Department of Pathology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA
Address for correspondence: Kelly E. Wood, MD, Stead Family Department of Pediatrics, University of Iowa Children’s Hospital, 200 Hawkins Dr, Iowa City, IA 52242, USA. Tel.: +1 319 356 7360; Fax: +1 319 384 6295; E-mail: Kellyemail@example.com.
Abstract: OBJECTIVES:Federal law mandates states to have policies and procedures to identify newborns exposed to maternal substance use during pregnancy. National guidelines for newborn drug testing are lacking; therefore, procedures are variable and determined by state law and local practices. In Iowa, maternal substance use during pregnancy is considered child abuse and must be reported.The objective of this study was to identify newborn drug testing policies and procedures among birthing hospitals in Iowa. METHODS:This was a cross sectional survey of all birthing hospitals in Iowa identified via the Statewide Perinatal Care Program. An electronic survey was sent to the representative at each affiliated hospital. RESULTS:Sixty-nine of 76 hospitals completed the survey for a 90.8% response rate. Newborn drug testing is ordered in 97.1% of responding hospitals with most testing 25% or less of newborns annually. The majority utilized a risk assessment tool (89.6%), although many (62.7%) also allowed for provider discretion. No hospital performed universal testing of all newborns. 86.6% of hospitals reported all positive newborn drug test results including illicit and/or prescription drugs to child protective services. 35.0% of hospitals notified mothers of the report and 45.5% offered substance abuse services and/or treatment to the mothers. CONCLUSIONS:Most Iowa birthing hospitals perform newborn drug testing and report all positive test results to child protective services. The majority use risk assessment tools. Maternal notification practices and referral for substance use disorder treatment are suboptimal and represent an area for future improvement.
Keywords: Prenatal drug abuse, substance exposed newborn, neonatal abstinence syndrome